###begin article-title 0
Functional analyses reveal an important role for tyrosine residues in the staphylococcal multidrug efflux protein QacA
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
The staphylococcal QacA multidrug efflux protein confers resistance to an exceptional number of structurally unrelated antimicrobial compounds. Aromatic amino acid residues have been shown to be highly important for the transport function of several multidrug transporters and are intimately involved in multidrug binding. This study investigated the structural and functional importance of the seven tyrosine residues in QacA by examining the phenotypic effect of incorporating conservative (aromatic) and non-conservative (non-aromatic) substitutions for these residues.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
Determination of the resistance profiles and analysis of drug transport assays revealed that non-conservative substitutions for most tyrosine residues influenced the QacA drug recognition spectrum. However, an aromatic residue at three tyrosine positions, 63, 410 and 429, was of importance for QacA-mediated transport and resistance to the majority of substrates tested.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
A tyrosine or phenylalanine residue at amino acid positions corresponding to 63 of QacA in related drug efflux proteins is found to be highly conserved. Therefore, an aromatic side chain at this position is likely to partake in a function common to these drug transporters, such as proton translocation or essential intramolecular contacts, whereas aromatic residues at the non-conserved 410 and 429 positions are expected to mediate a QacA-specific function, possibly forming or stabilising part of the QacA drug binding region.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 194 195 194 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 196 197 196 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 228 233 228 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qacA </italic>
###xml 330 351 330 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus</italic>
###xml 352 353 352 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 354 355 354 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 459 469 459 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 596 597 596 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 598 599 598 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 315 320 <span type="species:ncbi:9606">human</span>
###xml 330 351 <span type="species:ncbi:1280">Staphylococcus aureus</span>
###xml 459 468 <span type="species:ncbi:1280">S. aureus</span>
The QacA multidrug efflux protein confers resistance to at least 30 structurally distinct monovalent or bivalent cationic lipophilic antimicrobials from at least 12 different chemical families [1,2]. Furthermore, genes encoding qacA or a highly related derivative are carried by widespread clinical isolates of the human pathogen Staphylococcus aureus[3-5]. Therefore, the QacA multidrug resistance protein facilitates an efflux mechanism by which strains of S. aureus may currently overcome control measures, such as the use of biocides within the clinical environment, and spread to new hosts [1,3].
###end p 9
###begin p 10
###xml 130 131 126 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 134 135 130 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 136 137 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 182 184 178 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 276 277 272 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 401 402 397 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 536 537 532 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 667 669 663 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 795 796 791 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 797 799 793 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 800 802 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 966 968 962 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
The QacA polypeptide is composed of 514 amino acid residues, organised into 14 alpha-helical transmembrane segments (TMS) (Figure 1) [6,7] and is classified as a member of the drug:H+ antiporter (DHA) 2 family of the major facilitator superfamily (MFS) of transport proteins [8]. Drug efflux mediated by QacA is powered by the proton-motive-force and can be described using Michaelis-Menton kinetics [9]. The drug binding region within QacA appears to contain distinct binding sites for monovalent and bivalent cationic antimicrobials [9]. Nonetheless, biochemical studies of TMS lining the binding region have suggested that these binding sites may be in proximity [10]. A clear requirement for an acidic residue in the recognition of bivalent cationic substrates by QacA has been established [6,10,11]. However, the location of this residue within the binding region is flexible and appears to influence the bivalent drug recognition spectrum of the QacA protein [11].
###end p 10
###begin p 11
###xml 0 65 0 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Secondary structure model of the QacA multidrug transport protein</bold>
###xml 181 182 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 183 184 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
Secondary structure model of the QacA multidrug transport protein. Topology of the QacA multidrug efflux protein based on hydropathy predictions and solvent accessibility analyses [6,7,10]. The membrane is depicted as a grey shaded band and the 14 TMS of QacA are shown in boxes numbered 1-14. The locations of the seven tyrosine residues and their amino acid substitutions within QacA are shown.
###end p 11
###begin p 12
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 890 892 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 893 895 893 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1210 1212 1207 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1473 1475 1470 1472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1476 1478 1473 1475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
Multidrug binding regions fundamentally differ from binding sites required to bind only a single drug or group of closely related drugs, in that they accommodate and form stabilising interactions with large numbers structurally diverse compounds. A number of studies have attempted to delineate the mechanisms by which multidrug binding occurs [12]. These studies, including the determination of several drug-bound crystal structures for multidrug binding proteins [13-16], have demonstrated that multidrug binding may be described as a process of "induced-fit", i.e., each compound localises to a position or positions within a multidrug binding region where it is best accommodated and its binding is stabilised by a particular sub-set of amino acid side chains lining the region. Common among the sub-sets of residues that mediate interactions with drug compounds are aromatic residues [13-16]. This is not surprising since the benzene group of aromatic side chains potentiates a range of molecular interactions which could stabilise binding of the typically hydrophobic, planar and often cationic substrates of multidrug binding proteins, including stacking, hydrophobic, pi-pi and cation-pi interactions [17]. Beyond drug binding within a secondary multidrug transport protein such as QacA, these types of molecular interactions could also play a role in other functions, such as translocation of coupling ions or the mediation of stabilising intramolecular contacts [18,19].
###end p 12
###begin p 13
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 533 534 533 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 537 538 537 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 539 540 539 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 779 780 779 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1200 1201 1200 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
A previous study investigating the significance of tryptophan residues within the QacA transport protein demonstrated that those more highly conserved among QacA-related transporters were the most functionally significant [20]. In the current study the importance of the benzene moiety within the tyrosine residues of the QacA transport protein was determined. Of the seven tyrosine residues in the QacA polypeptide, four are known or predicted to be membrane embedded and three are thought to be located within loop regions (Figure 1) [6,7,10]. The aromaticity of the tyrosine residue at position 63 of QacA (Y63) is highly conserved among DHA family transporters; a tyrosine, or in some cases a phenylalanine, is almost exclusively found at this position among these proteins [8]. Therefore, this residue may function in a role common to these drug efflux proteins, whereas the remaining six tyrosine residues could partake in functions unique to QacA. Conservative and non-conservative substitutions in terms of side-chain aromaticity, phenylalanine and alanine, serine and/or valine, respectively, were made for each of the tyrosine residues in QacA and the mutants functionally analysed (Figure 1).
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Strains, plasmids, media and reagents
###end title 15
###begin p 16
###xml 4 12 4 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 29 33 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">supE</italic>
###xml 41 44 33 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lac</italic>
###xml 55 58 45 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lac</italic>
###xml 69 73 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hsdR</italic>
###xml 76 80 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">recA</italic>
###xml 82 86 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">endA</italic>
###xml 88 92 74 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gyrA</italic>
###xml 95 98 81 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">thi</italic>
###xml 100 104 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">relA</italic>
###xml 108 110 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 214 222 200 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 231 235 217 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">supE</italic>
###xml 237 241 223 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">supF</italic>
###xml 243 247 229 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">hsdR</italic>
###xml 249 252 235 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">met</italic>
###xml 255 257 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 365 370 351 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qacA </italic>
###xml 386 388 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 403 411 389 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 504 507 489 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1 </sup>
###xml 4 11 <span type="species:ncbi:562">E. coli</span>
###xml 214 221 <span type="species:ncbi:562">E. coli</span>
###xml 403 410 <span type="species:ncbi:562">E. coli</span>
The E. coli strain DH5alpha [supE44 DeltalacU169 (phi80lacZDeltaM15) hsdR17 recA1 endA1 gyrA96 thi-1relA1] [21] was used for routine plasmid cloning procedures, Western blot analyses and ethidium transport assays. E. coli BHB2600 (supE, supF, hsdR, met) [22] was used in MIC analyses. The plasmids used were pBluescript II SK (Stratagene) and the pBluescript-based qacA clone, pSK4322 [10]. Cultures of E. coli cells were grown in Luria-Bertani media. Ampicillin was used at a concentration of 100 mug ml-1 for plasmid selection where appropriate.
###end p 16
###begin p 17
###xml 125 126 125 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
Benzalkonium chloride, chlorhexidine dihydrochloride, dequalinium chloride, ethidium bromide, pyronin Y and carbonyl cyanide m-chlorophenylhydrazone were purchased from Sigma and diamidinodiphenylamine dihydrochloride was obtained from Rhone-Poulenc Rorer (Dagenham, UK). All other chemicals were of at least reagent grade and purchased from commercial sources.
###end p 17
###begin title 18
Substitution of wild-type tyrosine residues
###end title 18
###begin p 19
###xml 360 365 360 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qacA </italic>
###xml 504 509 504 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qacA </italic>
###xml 523 528 523 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qacA </italic>
The tyrosine residues within QacA were individually substituted using site-directed mutagenesis by the Stratagene QuikChange method. Pairs of complementary oligonucleotide primers (GeneWorks, Australia) were designed with two positions of degeneracy to insert alanine, phenylalanine, serine or valine substitutions for each of the seven tyrosine codons in the qacA gene carried on pSK4322. The primer pairs also incorporated a silent mutation which introduced an endonuclease restriction site within the qacA sequence. The qacA gene sequences within mutagenised pSK4322 derivatives, containing an introduced restriction site, were sequenced (Australian Genomic Research Facility, Brisbane) in their entirety to identify the incorporated amino acid changes and to ensure that undesired secondary mutations had not been introduced elsewhere in the genes. Gene sequences were stored and analysed using Sequencher version 4.2.2 (Gene Codes Corp.).
###end p 19
###begin title 20
Western blot analyses
###end title 20
###begin p 21
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 102 106 98 102 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600 </sub>
###xml 367 369 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 513 517 509 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 0 7 <span type="species:ncbi:562">E. coli</span>
E. coli DH5alpha cells harbouring pSK4322-derived plasmids expressing QacA mutants were cultured to OD600 = 0.6. Equal volumes of cells were collected, lysed and electrophoresed on a 10% sodium dodecyl sulphate polyacrylamide gel electrophoresis gel. Proteins were transferred to polyvinylidene difluoride membrane and probed using an anti-QacA polyclonal antiserum [10] and a colourimetric detection system. Membranes were scanned with a BioRad GS-710 calibrated imaging densitometer and analysed by Quantity One(R) software (BioRad). Mutant protein expression levels were expressed as a percentage of the wild-type protein.
###end p 21
###begin title 22
Minimum inhibitory concentration analyses
###end title 22
###begin p 23
###xml 172 174 171 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 201 203 199 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 230 232 227 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 270 272 266 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 297 299 292 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 328 330 322 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 332 340 326 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 332 339 <span type="species:ncbi:562">E. coli</span>
MIC analyses were conducted using solid Luria-Bertani agar media supplemented with antimicrobial compounds in the following concentration ranges: benzalkonium, 20-70 mug ml-1, chlorhexidine 1-20 mug ml-1, dequalinium 20-400 mug ml-1, diamidinodiphenylamine 50-500 mug ml-1, ethidium 50-1800 mug ml-1, and pyronin Y 25-600 mug ml-1. E. coli BHB2600 cells carrying pSK4322-derived plasmids encoding each QacA mutant protein were grown to equivalent densities in the late exponential phase then diluted 1:200 and replica plated onto plates containing increasing concentrations of antimicrobials. Plates were incubated at 37degreesC for up to 48 hours and the MIC determined as the lowest concentration of antimicrobial compound required to fully inhibit bacterial growth.
###end p 23
###begin title 24
Kinetic transport studies
###end title 24
###begin p 25
###xml 92 93 92 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 108 116 108 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 215 219 211 215 <sub xmlns:xlink="http://www.w3.org/1999/xlink">650 </sub>
###xml 394 395 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m</italic>
###xml 108 115 <span type="species:ncbi:562">E. coli</span>
Fluorimetric ethidium transport studies were conducted essentially as described previously [9,23]. Briefly, E. coli DH5alpha cells carrying pSK4322-derived plasmids encoding each QacA mutant protein were grown to OD650 = 0.6, then washed and resuspended in 20 mM HEPES buffer. Cells were loaded with ethidium at concentrations ranging from 0.1-25 muM in the presence of 10 muM carbonyl cyanide m-chlorophenylhydrazone. Ethidium loaded cells were again washed and resuspended in 20 mM HEPES, before transport was initiated by the addition of 500 mM sodium formate. Transport was monitored fluorimetrically using a Hitachi 4500 fluorescence spectrophotometer with excitation and emission wavelengths of 530 and 610 nm, respectively.
###end p 25
###begin title 26
Results
###end title 26
###begin title 27
Construction of site-directed QacA tyrosine mutants
###end title 27
###begin p 28
###xml 170 175 170 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qacA </italic>
###xml 778 779 778 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1024 1025 1024 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
Site-directed mutagenesis using oligonucleotide primers degenerate at two nucleotide positions within each targeted codon was used to exchange tyrosine codons within the qacA gene carried on pSK4322 for alanine, valine, serine, and/or phenylalanine. Phenylalanine substitutions for each tyrosine residue were specifically isolated to determine the effect of conservative (aromatic) tyrosine substitutions on QacA function. Additionally, mutants encoding at least one of alanine, serine or valine in place of each tyrosine residue were isolated to examine the importance of side-chain aromaticity at tyrosine positions for the catalytic activity of the QacA transporter. In total, genes encoding 16 tyrosine-substituted QacA mutants were isolated for functional analyses (Figure 1). The expression of these QacA variants was assessed using semi-quantitative Western blot analysis. Each of the QacA mutants was shown to be expressed at a level facilitating functional studies, ranging from 32 to 132% of wild-type QacA (Table 1).
###end p 28
###begin p 29
Phenotypic profiles of QacA tyrosine mutants
###end p 29
###begin p 30
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 32 40 32 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 32 39 <span type="species:ncbi:562">E. coli</span>
a MIC values were determined in E. coli BHB2600 cells expressing wild-type QacA or a mutant derivative and represent the lowest concentration of substrate required to fully inhibit bacterial growth.
###end p 30
###begin p 31
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
b MIC experiments were conducted in at least triplicate and the median value is presented.
###end p 31
###begin p 32
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c </sup>
c QacA protein expression levels are the average of two repeat experiments.
###end p 32
###begin p 33
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d </sup>
d Abbreviations: Qacs, quaternary ammonium compounds; Bg, biguanidines; Di, diamidines; Et, ethidium; PyY, pyronin Y; Bc, benzalkonium; Dc, dequalinium; Ch, chlorhexidine; Dd, diamidinodiphenylamine.
###end p 33
###begin title 34
Drug resistance profiles of the QacA tyrosine mutants
###end title 34
###begin p 35
In order to gauge the functional consequences of QacA tyrosine substitutions in the recognition and transport of a range of chemically diverse QacA substrates, minimum inhibitory concentration (MIC) analyses were conducted. The resistance levels conferred by the QacA mutant proteins to six compounds, representing five different chemical classes were tested: monovalent dyes (ethidium and pyronin Y); monovalent quaternary ammonium compounds (benzalkonium); bivalent quaternary ammonium compounds (dequalinium); biguanidines (chlorhexidine); and diamidines (diamidinodiphenylamine).
###end p 35
###begin p 36
###xml 171 172 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
Phenylalanine substitutions for the majority of the tyrosine residues in QacA did not have a significant bearing on the capacity of QacA to mediate drug resistance (Table 1). Indeed, only the Y410F derivative was notably affected and then only in its capacity to mediate resistance to the monovalent dyes ethidium and pyronin Y. Similarly, the non-aromatic substituted Qac mutants, Y315A, Y366V and Y501V, had no significant effect on drug resistance. In contrast, Y63V, Y410A, Y410V, and Y429S non-aromatic substitutions significantly reduced or abolished QacA-mediated resistance to most representative QacA substrates. Thus, these results suggest that aromatic residues at positions 63, 410 and 429 participate in an aspect of QacA-mediated transport common to all substrates. These aromatic residues may function mechanistically, e.g., in proton translocation or in facilitating intramolecular conformational transitions required for substrate transport. Alternatively, these residues could compose part of the QacA binding region universal to all substrates or stabilise the binding region in the absence of substrate. Of the remaining amino acid substitutions examined, three had slight differential effects on substrate resistance where Y358S and Y366A abolished QacA-mediated resistance to the bivalent quaternary ammonium compound dequalinium.
###end p 36
###begin title 37
Kinetics of ethidium transport mediated by QacA tyrosine mutants
###end title 37
###begin p 38
###xml 273 274 273 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 467 468 467 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 590 591 590 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 591 593 591 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m </italic>
###xml 591 593 591 593 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>m </italic></sub>
###xml 865 866 865 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
To complement the MIC analyses the kinetics of ethidium transport were determined for each tyrosine-substituted QacA mutant. In line with their inability to confer resistance to ethidium, the Y63V, Y410A/V/F and Y429S QacA mutants failed to mediate ethidium efflux (Figure 2). Furthermore, mutants conferring only low-level ethidium resistance, such as Y358S, displayed lower maximal rates of transport than the wild-type protein and other functional mutants (Figure 2). The remaining mutants displayed rates of ethidium transport approximately in line with the wild-type QacA protein. The Km values derived for the mutants functional in ethidium transport were approximately equal to, or in some cases less than, that determined for the wild-type QacA protein and do not point towards reduced ethidium recognition as a result of the incorporated mutations (Figure 2).
###end p 38
###begin p 39
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Kinetics of ethidium transport by QacA tyrosine mutants</bold>
###xml 205 206 205 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">V</italic>
###xml 206 210 206 210 <sub xmlns:xlink="http://www.w3.org/1999/xlink">max </sub>
###xml 301 303 297 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 309 310 305 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K</italic>
###xml 310 312 306 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">m </italic>
###xml 310 312 306 308 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>m </italic></sub>
Kinetics of ethidium transport by QacA tyrosine mutants. Cells expressing each QacA derivative were loaded with various concentrations of ethidium and efflux monitored fluorimetrically after energisation. Vmax values (black bars) represent the maximal change in fluorescent units per second (DeltaFU S-1) and Km values (white bars) are presented as muM ethidium. Transport assays were conducted in at least triplicate and the results of a representative experiment are shown.
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 658 675 658 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 720 730 720 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. aureus </italic>
###xml 887 889 887 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 890 892 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 893 895 893 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1294 1296 1294 1296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1433 1438 1433 1438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qacA </italic>
###xml 1453 1455 1453 1455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1880 1882 1880 1882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1883 1885 1883 1885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1886 1888 1886 1888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 658 674 <span type="species:ncbi:562">Escherichia coli</span>
###xml 720 729 <span type="species:ncbi:1280">S. aureus</span>
The benzene moiety of aromatic amino acids affords these residues versatility in molecular interactions, which is ideal within the context of a multidrug transporter. For example, drug binding, a key step in drug translocation by multidrug transporters, requires the use of multidrug binding regions that accommodate and stabilise the binding of a diverse array of chemical compounds. Such binding regions benefit from side-chains, such as those of aromatic residues, capable of facilitating a range of molecular contacts with the various structural moieties composing different drug substrates. Indeed, multidrug binding regions, including those within the Escherichia coli multidrug transporters AcrB and EmrE and the S. aureus QacA regulator protein QacR, which binds a similar range of lipophilic cationic substrates to the QacA transporter, are lined by numerous aromatic residues [13-16,24]. A number of these residues have been determined to facilitate diverse structural interactions with different substrates, making them key mediators of multidrug binding. Furthermore, aromatic residues, Y92 and Y93 in particular, were seen to function as "drug surrogates" that stabilise the multidrug binding region of the QacR regulator in the absence of drug and are expelled upon drug binding [16]. Interestingly, the expulsion of Y92 and Y93 in QacR leads to a conformational change that dissociates the protein from DNA and allows qacA transcription [16]. It is interesting to speculate that a similar scenario within a multidrug transporter could provide the impetus for initiating a translocation cycle. Beyond their roles within multidrug binding regions, aromatic residues have been shown to influence proton coupling within multidrug transporters and may also play important structural roles in mediating TMS interactions or in guiding the depth of TMS membrane insertion [18,25,26].
###end p 41
###begin p 42
###xml 157 158 157 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 861 862 861 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 871 872 871 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1124 1125 1124 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1126 1128 1126 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1300 1308 1300 1308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 1326 1328 1326 1328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1300 1307 <span type="species:ncbi:562">E. coli</span>
This study investigated the importance of a benzene moiety at amino acid positions occupied by tyrosine residues with the QacA multidrug transporter (Figure 1). Overall, the tyrosine residues in the QacA protein were readily replaceable with phenylalanine, indicating that the hydroxyl group of the tyrosine side chains is not essential in QacA-mediated transport function, although, a hydroxyl moiety may be important at position 410 to allow recognition of the monovalent dyes ethidium and pyronin Y. In contrast, the benzene groups of the QacA tyrosine residues were less dispensable. This was particularly evident for the QacA Y63, Y410 and Y429 tyrosines, which when replaced with non-aromatic residues resulted in large reductions or the abolition of resistance to most representative compounds and the complete loss of ethidium transport capacity (Table 1; Figure 2). This suggests that aromatic side chains at these positions are of general importance for QacA-mediated transport function. Since the aromaticity of Y63 in QacA is highly conserved among DHA family transporters with varied drug recognition profiles [8,23], it is likely that the benzene moiety of this side chain functions in a mechanistic role common to these proteins, possibly proton coupling as demonstrated for Y4 of the E. coli EmrE transporter [18]. Although Y410 and Y429 of QacA are not conserved among related proteins, these residues may also function mechanistically in the QacA transport process, possibly in mediating contacts between distal parts of the QacA polypeptide. Given that the Y410F substitution affected only the transport of monovalent dyes, Y410 may face into the QacA multidrug binding region and mediate interactions with these substrates via its hydroxyl group. In such a location, this residue may also interact with other substrates via its benzene moiety or could function similarly to Y92 and Y93 of QacR and stabilise the QacA binding region in the absence of drugs. Non-aromatic substitutions for Y358 and Y366 prevented resistance to dequalinium, implying that these residues may function in dequalinium binding or stabilise the dequalinium binding site.
###end p 42
###begin title 43
Conclusion
###end title 43
###begin p 44
Overall, the results of this study suggest a functional need to maintain the aromaticity of a number of tyrosine residues within the QacA transport protein. In several cases, modification of these residues for a non-aromatic residue resulted in an altered drug recognition spectrum, hinting at an involvement of these side chains in drug binding. This finding is in keeping with previous studies of multidrug binding proteins which have identified aromatic residues as key mediators of multidrug binding.
###end p 44
###begin title 45
Abbreviations
###end title 45
###begin p 46
###xml 11 13 11 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
DHA: drug:H+ antiporter; MFS: major facilitator superfamily; MIC: minimum inhibitory concentration; TMS: alpha-helical transmembrane segment.
###end p 46
###begin title 47
Authors' contributions
###end title 47
###begin p 48
JW performed the molecular experiments. KAH performed the protein analyses and drafted the manuscript. RAS and MHB conceived the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
###end p 48
###begin title 49
Acknowledgements
###end title 49
###begin p 50
This research was supported by Project Grants 301938 and 457391 from the National Health and Medical Research Council (Australia).
###end p 50
###begin article-title 51
Staphylococcal multidrug efflux protein QacA
###end article-title 51
###begin article-title 52
###xml 32 53 32 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus</italic>
###xml 32 53 <span type="species:ncbi:1280">Staphylococcus aureus</span>
QacA multidrug efflux pump from Staphylococcus aureus: comparative analysis of resistance to diamidines, biguanidines and guanylhydrazones
###end article-title 52
###begin article-title 53
Active export proteins mediating drug resistance in staphylococci
###end article-title 53
###begin article-title 54
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qacA</italic>
###xml 91 93 91 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B </italic>
###xml 97 101 97 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">smr </italic>
###xml 126 148 126 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus </italic>
###xml 126 147 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Susceptibilities to antiseptic agents and distribution of antiseptic-resistance genes qacA/B and smr of methicillin-resistant Staphylococcus aureus isolated in Asia during 1998 and 1999
###end article-title 54
###begin article-title 55
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qacA</italic>
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qacB </italic>
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qacC </italic>
###xml 135 156 135 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus</italic>
###xml 135 156 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Distribution of the antiseptic resistance genes qacA, qacB and qacC in 497 methicillin-resistant and -susceptible European isolates of Staphylococcus aureus
###end article-title 55
###begin article-title 56
###xml 49 70 49 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus</italic>
###xml 49 70 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Multidrug resistance proteins QacA and QacB from Staphylococcus aureus: Membrane topology and identification of residues involved in substrate specificity
###end article-title 56
###begin article-title 57
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">qacA </italic>
###xml 53 74 53 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphylococcus aureus</italic>
###xml 53 74 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Efflux-mediated antiseptic resistance gene qacA from Staphylococcus aureus: common ancestry with tetracycline- and sugar-transport proteins
###end article-title 57
###begin article-title 58
Proton-dependent multidrug efflux systems
###end article-title 58
###begin article-title 59
Bioenergetics of the staphylococcal multidrug export protein QacA: identification of distinct binding sites for monovalent and divalent cations
###end article-title 59
###begin article-title 60
Role of transmembrane segment 10 in efflux mediated by the staphylococcal multidrug transport protein QacA
###end article-title 60
###begin article-title 61
###xml 30 51 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Transmembrane helix 12 of the Staphylococcus aureus multidrug transporter QacA lines the bivalent drug binding pocket
###end article-title 61
###begin article-title 62
The ostensible paradox of multidrug recognition
###end article-title 62
###begin article-title 63
Multidrug-binding transcription factor QacR binds the bivalent aromatic diamidines DB75 and DB359 in multiple positions
###end article-title 63
###begin article-title 64
Crystal structures of a multidrug transporter reveal a functionally rotating mechanism
###end article-title 64
###begin article-title 65
Crystal structures of QacR-diamidine complexes reveal additional multidrug-binding modes and a novel mechanism of drug charge neutralization
###end article-title 65
###begin article-title 66
Structural mechanisms of QacR induction and multidrug recognition
###end article-title 66
###begin article-title 67
Cation-pi interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp
###end article-title 67
###begin article-title 68
Identification of tyrosine residues critical for the function of an ion-coupled multidrug transporter
###end article-title 68
###begin article-title 69
Cation-pi interactions in structural biology
###end article-title 69
###begin article-title 70
Analysis of tryptophan residues in the staphylococcal multidrug transporter QacA reveals long-distance functional associations of residues on opposite sides of the membrane
###end article-title 70
###begin article-title 71
###xml 29 46 29 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 29 45 <span type="species:ncbi:562">Escherichia coli</span>
Studies on transformation in Escherichia coli with plasmids
###end article-title 71
###begin article-title 72
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
In vitro packaging of lambda and cosmid DNA
###end article-title 72
###begin article-title 73
Functional effects of intramembranous proline substitutions in the staphylococcal multidrug transporter QacA
###end article-title 73
###begin article-title 74
X-ray structure of EmrE supports dual topology model
###end article-title 74
###begin article-title 75
The aromatic residues Trp and Phe have different effects on the positioning of a transmembrane helix in the microsomal membrane
###end article-title 75
###begin article-title 76
Specificity in transmembrane helix-helix interactions mediated by aromatic residues
###end article-title 76

